Using Quantra bedside clot testing to guide blood transfusions during liver transplant
Official title: Assessment of a Quantra-guided Transfusion Algorithm in Liver Transplantation
Run by University Hospital, Toulouse · NCT06749405 · Data updated 2026-11-12
This will test whether using Quantra bedside clot testing during liver transplants can reduce bleeding and the need for blood transfusions in adults with end-stage liver disease.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 56 (estimated) |
| Sponsor | University Hospital, Toulouse Academic / other |
| Locations | 1 site (Toulouse) |
| Status | Recruiting |
| Started | March 8, 2025 |
| Main results expected | March 2027 |
| Study ends | March 2027 |
| Registry record updated | September 22, 2025 |
| Trial ID | NCT06749405 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Adults aged 18 or older with end-stage liver disease scheduled for liver transplantation who can provide informed consent and are not listed for multi-organ transplant are ideal candidates.
✕Probably not a fit
Patients undergoing multi-organ transplantation, those with congenital bleeding disorders, pregnant or breastfeeding women, or people under legal protection are excluded and unlikely to benefit from this protocol.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This interventional study compares a transfusion algorithm guided by the Quantra bedside viscoelastic sonorheometry device with a conventional transfusion approach in adults undergoing orthotopic liver transplantation. Participants receive intraoperative haemostatic management according to one of the two predefined algorithms, and transfusion volumes and bleeding-related outcomes are recorded. The trial focuses on real-time guidance of blood-product administration during the perioperative period to respond to dynamic coagulation changes common in end-stage liver disease. Primary outcomes include transfusion requirements and measures of intraoperative bleeding, with safety monitored throughout.
Why it matters
Potential benefit: If successful, the Quantra-guided approach could reduce blood transfusions and bleeding during liver transplantation, potentially lowering complications and resource use.
How similar studies have gone: Viscoelastic-guided transfusion strategies using TEG or ROTEM have shown benefit in some surgical settings, but Quantra's sonorheometric approach is newer and less extensively validated in liver transplantation.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Patients aged 18 years or older * Patient with ESLD undergoing liver transplantation * Individuals affiliated with or beneficiaries of a social security scheme * Free and informed written consent obtained in writing from the patient, or where applicable from the trusted person/family member/close relative Non-inclusion Criteria: * Multi-organ transplantation * Congenital haemostasis disorder (such as haemophilia) * Patient under juridical protection (persons deprived of liberty or under curatorship or guardianship or safeguard of justice) * Pregnant or breast-feeding woman * Patient already enrolled in another interventional study with primary or secondary objective of reducing perioperative bleeding or transfusion
Where it's running
-
Toulouse University Hospital
Toulouse, France Recruiting
Study contacts
- Principal investigator: Guillaume PORTA BONETE, Md — University Hospital, Toulouse
- Study coordinator: Guillaume PORTA BONETE, Md
- Email: porta-bonete.g@chu-toulouse.fr
- Phone: 561323565
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Everolimus-based calcineurin-free immunosuppression one year after liver transplant
This trial tests whether switching to or using everolimus with reduced calcineurin inhibitors after year one post-liver transplant can protect kidney function while maintaining graft health in adults at low rejection risk.
-
Sleep quality and its determinants during the liver transplant pathway
This study tests how sleep quality changes from before liver transplantation to six months after, in adults on the transplant waitlist at a single hospital.
-
Preoperative CIMT and Intraoperative Hemodynamics in Liver Transplant
This study looks at whether a higher carotid IMT measured before surgery is linked to more unstable blood pressure during liver transplant.
-
Reference framework for outcomes after machine-preserved liver transplantation in Europe
This study tests how liver transplants that use machine perfusion perform in real-world practice, to see how different perfusion methods relate to outcomes for adults in Europe.
-
Even protein distribution plus exercise for people awaiting liver transplant
This trial tests whether spreading daily protein evenly and combining it with a 12-week exercise program improves nutrition, muscle mass, and function in people waiting for a liver transplant compared with uneven protein timing or usual advice.
-
Preoperative Carbohydrate Loading Before Liver Transplant
This study tests whether drinking a carbohydrate beverage before anesthesia helps liver transplant patients recover faster.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.